Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, 75 Francis Street, PBB-B3, Boston, MA 02115, USA.
Arthritis Res Ther. 2011 Apr 28;13(2):211. doi: 10.1186/ar3306.
Pain is a key component of most rheumatologic diseases. In fibromyalgia, the importance of central nervous system pain mechanisms (for example, loss of descending analgesic activity and central sensitization) is well documented. A few studies have also noted alterations in central pain processing in osteoarthritis, and some data, including the observation of widespread pain sensitivity, suggest that central pain-processing defects may alter the pain response in rheumatoid arthritis patients. When central pain is identified, different classes of analgesics (for example, serotonin-norepinephrine reuptake inhibitors, α2δ ligands) may be more effective than drugs that treat peripheral or nociceptive pain (for example, nonsteroidal anti-inflammatory drugs and opioids).
疼痛是大多数风湿性疾病的一个主要组成部分。在纤维肌痛中,中枢神经系统疼痛机制(例如,下行镇痛活性丧失和中枢敏化)的重要性已得到充分证明。一些研究也注意到骨关节炎患者中枢疼痛处理的改变,一些数据,包括广泛疼痛敏感性的观察,表明中枢疼痛处理缺陷可能改变类风湿关节炎患者的疼痛反应。当确定存在中枢性疼痛时,不同类别的镇痛药(例如,5-羟色胺去甲肾上腺素再摄取抑制剂、α2δ 配体)可能比治疗外周或伤害性疼痛的药物(例如,非甾体抗炎药和阿片类药物)更有效。